220 related articles for article (PubMed ID: 24879900)
1. Silymarin and its constituents in cardiac preconditioning.
Zholobenko A; Modriansky M
Fitoterapia; 2014 Sep; 97():122-32. PubMed ID: 24879900
[TBL] [Abstract][Full Text] [Related]
2. Hepatoprotective herbal drug, silymarin from experimental pharmacology to clinical medicine.
Pradhan SC; Girish C
Indian J Med Res; 2006 Nov; 124(5):491-504. PubMed ID: 17213517
[TBL] [Abstract][Full Text] [Related]
3. Chemoprotective effect of plant phenolics against anthracycline-induced toxicity on rat cardiomyocytes. Part I. Silymarin and its flavonolignans.
Chlopcíková S; Psotová J; Miketová P; Simánek V
Phytother Res; 2004 Feb; 18(2):107-10. PubMed ID: 15022159
[TBL] [Abstract][Full Text] [Related]
4. Influence of silymarin and its flavonolignans on H(2)O(2)-induced oxidative stress in human keratinocytes and mouse fibroblasts.
Svobodová A; Walterová D; Psotová J
Burns; 2006 Dec; 32(8):973-9. PubMed ID: 17011711
[TBL] [Abstract][Full Text] [Related]
5. Milk thistle.
Rainone F
Am Fam Physician; 2005 Oct; 72(7):1285-8. PubMed ID: 16225032
[TBL] [Abstract][Full Text] [Related]
6. Milk thistle in liver diseases: past, present, future.
Abenavoli L; Capasso R; Milic N; Capasso F
Phytother Res; 2010 Oct; 24(10):1423-32. PubMed ID: 20564545
[TBL] [Abstract][Full Text] [Related]
7. Preventive effect of silymarin in cerebral ischemia-reperfusion-induced brain injury in rats possibly through impairing NF-κB and STAT-1 activation.
Hou YC; Liou KT; Chern CM; Wang YH; Liao JF; Chang S; Chou YH; Shen YC
Phytomedicine; 2010 Oct; 17(12):963-73. PubMed ID: 20833521
[TBL] [Abstract][Full Text] [Related]
8. New therapeutic potentials of milk thistle (Silybum marianum).
Milić N; Milosević N; Suvajdzić L; Zarkov M; Abenavoli L
Nat Prod Commun; 2013 Dec; 8(12):1801-10. PubMed ID: 24555302
[TBL] [Abstract][Full Text] [Related]
9. Cardioprotective effect of 2,3-dehydrosilybin preconditioning in isolated rat heart.
Gabrielová E; Bartošíková L; Nečas J; Modrianský M
Fitoterapia; 2019 Jan; 132():12-21. PubMed ID: 30385403
[TBL] [Abstract][Full Text] [Related]
10. Protective effects of silymarin, a milk thistle (Silybium marianum) derivative on ethanol-induced oxidative stress in liver.
Das SK; Vasudevan DM
Indian J Biochem Biophys; 2006 Oct; 43(5):306-11. PubMed ID: 17133738
[TBL] [Abstract][Full Text] [Related]
11. A silychristin isomer and variation of flavonolignan levels in milk thistle (Silybum marianum) fruits.
Smith WA; Lauren DR; Burgess EJ; Perry NB; Martin RJ
Planta Med; 2005 Sep; 71(9):877-80. PubMed ID: 16206045
[TBL] [Abstract][Full Text] [Related]
12. Safety and toxicity of silymarin, the major constituent of milk thistle extract: An updated review.
Soleimani V; Delghandi PS; Moallem SA; Karimi G
Phytother Res; 2019 Jun; 33(6):1627-1638. PubMed ID: 31069872
[TBL] [Abstract][Full Text] [Related]
13. Silymarin selectively protects human renal cells from cisplatin-induced cell death.
Ninsontia C; Pongjit K; Chaotham C; Chanvorachote P
Pharm Biol; 2011 Oct; 49(10):1082-90. PubMed ID: 21591838
[TBL] [Abstract][Full Text] [Related]
14. Identification of hepatoprotective flavonolignans from silymarin.
Polyak SJ; Morishima C; Lohmann V; Pal S; Lee DY; Liu Y; Graf TN; Oberlies NH
Proc Natl Acad Sci U S A; 2010 Mar; 107(13):5995-9. PubMed ID: 20231449
[TBL] [Abstract][Full Text] [Related]
15. Anti-inflammatory and anti-arthritic activities of silymarin acting through inhibition of 5-lipoxygenase.
Gupta OP; Sing S; Bani S; Sharma N; Malhotra S; Gupta BD; Banerjee SK; Handa SS
Phytomedicine; 2000 Mar; 7(1):21-4. PubMed ID: 10782486
[TBL] [Abstract][Full Text] [Related]
16. [Milk Thistle (Silybum Marianum) as a Supportive Phytotherapeutic Agent in Oncology].
Frassová Z; Rudá-Kučerová J
Klin Onkol; 2017; 30(6):426-432. PubMed ID: 29271213
[TBL] [Abstract][Full Text] [Related]
17. Milk thistle (Silybum marianum) for the therapy of liver disease.
Flora K; Hahn M; Rosen H; Benner K
Am J Gastroenterol; 1998 Feb; 93(2):139-43. PubMed ID: 9468229
[TBL] [Abstract][Full Text] [Related]
18. A review of the bioavailability and clinical efficacy of milk thistle phytosome: a silybin-phosphatidylcholine complex (Siliphos).
Kidd P; Head K
Altern Med Rev; 2005 Sep; 10(3):193-203. PubMed ID: 16164374
[TBL] [Abstract][Full Text] [Related]
19. Anticancer potential of silymarin: from bench to bed side.
Agarwal R; Agarwal C; Ichikawa H; Singh RP; Aggarwal BB
Anticancer Res; 2006; 26(6B):4457-98. PubMed ID: 17201169
[TBL] [Abstract][Full Text] [Related]
20. Silymarin as a new hepatoprotective agent in experimental cholestasis: new possibilities for an ancient medication.
Crocenzi FA; Roma MG
Curr Med Chem; 2006; 13(9):1055-74. PubMed ID: 16611084
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
